Psychological distress common after a heart attack, may lead to future heart conditions
Statement Highlights:
An estimated 33-50% of heart attack survivors may experience some form of psychological distress, including…
Genetic mutation in some East Asians linked to aldehyde storm and increased liver disease risk
Researchers have identified the mechanism by which a common genetic mutation increases liver disease risk. Their findings suggest…
New Review Explores the Shared Genetic Backgrounds of Cardiovascular Diseases and Psoriasis
Image Credit: © irina__g – stock.adobe.com A recent narrative review explores the complex interplay between specific genetic polymorphisms…
Study uncovers three-way relationships between gut fungi, genetics and disease risk
A new genome-wide study uncovers evidence of the first three-way relationships between human genetic variation, variation in the…
This Common Heart Attack Drug May Actually Be Worthless for Most People
A common treatment given after heart attacks may not be worthwhile for a large segment of the population.…
Statins should be available over the counter
Welcome to The Workup, a new First Opinion column from Vishal Khetpal. There’s a saying in medicine: Statins…
3 Simple Habits a Longevity Doctor Who Reversed His Biological Age by 11 Years Swear by
Dr. Kurt Hong, an obesity doctor, nutrition researcher, and professor of medicine and aging, takes leading a healthy…
Heart health: US cardiologist reveals why LDL cholesterol above 60 is a red flag for your heart; recommends early blood tests |
Heart disease is still the #1 killer in the U.S., claiming more lives each year. In 2022 alone,…
Data gaps worsen cardiovascular health inequities in racialized and Indigenous communities
A new study has revealed that racialized and Indigenous communities across Europe, North America, and Central America face…
Is a statin drug right for you? Researchers try to right-size the risk
It’s a math problem with life-and-death consequences. When a new and improved model for estimating the risk of…
Health Canada approves Ozempic® to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease
Ozempic® is the first-and-only medication indicated for both the once-weekly treatment of adult patients with type 2 diabetes…
New high blood pressure guideline emphasizes prevention, early treatment to reduce CVD risk
Guideline Highlights:
Nearly half of all adults in the U.S. have high blood pressure (≥130/80 mm Hg),…